Covered recipient · General Payments record
ALBERTO CONTRERAS
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2022–2024
$2,227.47
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $186.48 | 8 |
| Education | $34.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $86.57 | 3 |
| Amgen Inc. | $39.20 | 2 |
| VERTEX PHARMACEUTICALS INCORPORATED | $33.15 | 1 |
| Xeris Pharmaceuticals, Inc. | $23.21 | 1 |
| E.R. Squibb & Sons, L.L.C. | $20.40 | 1 |
| Shionogi Inc | $18.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.56 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111553556 | CMS |
| Amgen Inc. | $23.64 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111553558 | CMS |
| Astellas Pharma US Inc | $22.92 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139340488 | CMS |
| Astellas Pharma US Inc | $34.99 | 08/21/2024 | Education | Undisputed | 01/23/2026 | 1139381234 | CMS |
| Astellas Pharma US Inc | $28.66 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139375369 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.40 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101767561 | CMS |
| Shionogi Inc | $18.94 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154337772 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $33.15 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105906037 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.21 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144585426 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.